Analysis Of Vectibix(R) Study Using New Gene Technology Helps To Advance Prospects For Personalized Medicine

Links shared publicly online about this topic.

  • 1,222
    total visits

Analysis Of Vectibix(R) Study Using New Gene Technology Helps To Advance Prospects For Personalized Medicine

medicalnewstoday.com —

Amgen (Nasdaq: AMGN) announced detailed results from a new biomarker analysis of the pivotal Phase 3 408 trial of Vectibix® (panitumumab) plus best supportive care (BSC) compared to BSC alon

View full resource at medicalnewstoday.com

Tags: Genetic, Colorectal Cancer Medication, Personalized Medicine, Genes, Vectibix, Amgen

  • Share

Most Recently Shared on April 22, 2010 at 10:06 pm By:

mnt_clinical MNT Clinical Trials

Analysis Of Vectibix(R) Study Using New Gene Technology Helps To Advance Prospects For Personalized Medicine http://mnt.to/3BBz

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Genetics News MNT Genetics News

MNT Pharma News MNT Pharma News

Advertisement